Armistice Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Armistice Capital’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000,000	Closed	-$6.32M	–	270
2022 Q4	$6.32M	Buy	+1,000,000	New	+$5.54M	0.11%	89

Armistice Capital's FSTX Position: Q1 2023 in Review

Armistice Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 1,000,000 shares — an estimated $6.32M sold.

Armistice Capital first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $6.32M in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Armistice Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Armistice Capital sold 1,000,000 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $6.32M.
Armistice Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Armistice Capital's F-star Therapeutics, Inc. Common Stock position peaked at $6.32M in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.